
Yuanshi Tech Raises Nearly RMB 300 Million Pre-A, Led by Legend Capital, for AI Virtual Cells
Yuanshi (Shanghai) Technology Co., Ltd. — the AI virtual cell (AIVC) company we call Yuanshi Tech — announced on 19 November 2026 that it completed a Pre-A round of nearly RMB 300 million, reported by Pedaily as a single-round funding record in China's AIVC sector, and confirmed by Jiemian.
Jason Lim is a Singapore-based presentation and sales coach and creator of the 1Pitch™ system; per his program page, he has coached since age 16 and is now in his 24th year.
Your opportunity: If you build hard technology, you can practise explaining it clearly before your next investor, hire or customer asks. Jason Lim's Presentation Skills Coaching Program uses the P.I.T.C.H. method and is by application. Bring your real pitch and work through it step by step. See the program.
What we know
- The round: nearly RMB 300 million Pre-A, announced 19 November 2026. Pedaily reported it as a record single round for China's AIVC sector; that claim is Pedaily's, not independently verified by us.
- Earlier rounds: back-to-back angel and angel+ rounds of nearly RMB 100 million.
- Lead and participants: led by Legend Capital, with Huaxia Lingtou, China Merchants China Fund, a JD-affiliated fund, CDH VGC and CMC Capital; Jiemian confirms the same lineup.
- Follow-ons: existing investors Monolith, Sinovation Ventures, Daotong Investment and Yanyuan Venture Capital increased their stakes, with Light Source Capital as exclusive financial advisor.
- The company, per Pedaily: a life-science foundation layer combining a raw biological data engine with a general cell model, aiming for AI to learn the dynamic causal logic of living systems and predict how cells respond under disease states, experimental conditions and interventions — run as a dry-wet closed loop of prediction, experimental validation, data feedback and model update.
- People: CEO Dr Wu Jiaqi holds a PhD in systems biology from Peking University, did postdoctoral research at Rockefeller University, and has bioinformatics and single-cell sequencing experience (per Pedaily; no verifiable public profile was found). CTO Dr Dong Mingze earned his B.S. at Peking University and a PhD in computational biology at Yale, and describes himself on his academic site as a Stanford postdoctoral fellow building foundation models for biology at Arc Institute.
- Sourcing note: figures are as reported by Chinese press. No official Yuanshi company website could be located, so we could not read a company announcement directly; the two reports corroborate each other on the amount, round, lead, participants and use of funds.
What the investors said
The round drew unusually specific language from its backers (all quotes below are translated from Chinese by us):
“Life science has cross-scale emergence; virtual cells model at the mesoscale — another upgrade in AI drug discovery after molecular models… We are delighted to partner with two young scientists.” — Legend Capital
“…a historic opportunity for AI to move from understanding language to understanding and predicting life.” — Huaxia Lingtou
“the two outstanding young scientists returning to China to start a company show the great potential for a world-class cell foundation model company to emerge in China.” — Huaxia Lingtou, on the founders
Wang Xiaoding, Chief Investment Officer at China Merchants China Fund, framed drug R&D as moving from traditional trial-and-error toward computable, predictable systems biology, per Pedaily (translated from Chinese by us).
Where the money goes
The capital is earmarked for data accumulation, automation platform construction, model iteration and team building — the inputs the closed loop needs before the loop can compound.
Related News
- The result to aim for is a pitch your audience can follow. The Presentation Skills Coaching Program uses the P.I.T.C.H. method, by application. Coached by Jason Lim, who has coached since age 16 (now his 24th year, per the program page).
- What Is Speaking with Impact Training and How Does It Change the Way You Communicate?
- What Is Keynote Speaking Training and Do You Actually Need It?
AD · Ad — promotional content from DreaMaker Ventures
DreamakerAI™ — All-in-One AI CRM & Business OS for Founders. Read the official page, check the details step by step, and decide whether it fits you and your team.
Our analysis: what this means for China, Singapore and Asia
Track 1 — where the capital sits. Anchor: Legend Capital led, and the co-investors are China-linked funds, per both reports. One reading: China-linked capital is backing life-science AI infrastructure, not only consumer and language AI.
Track 2 — where the talent comes from. Anchor: Huaxia Lingtou's comment on two young scientists returning to China to start a company (quoted above), and both founders' US-linked research training. One reading: talent returning to build where capital concentrates is the pattern investors are betting on.
Track 3 — the Singapore and Asia angle. Anchor: both reports place the company in Shanghai, and neither mentions Singapore or Southeast Asia; there is no documented Singapore connection, and we say so plainly. One reading, ours alone: when deep-science rounds this size are reported, founders pitching for similar capital in Singapore and across Asia may find that explaining frontier science simply matters.
The pitch lesson: borrow a reference point, then give one proof point
Investors here did not describe Yuanshi in technical vocabulary alone; they reached for analogies — AI moving from understanding language to understanding and predicting life, or another upgrade in AI drug discovery after molecular models. A hard-science founder can copy that structure: open with a reference point the room already knows, then land one proof point — the closed loop of prediction, experiment, feedback and update. We do not claim analogies won the round; we note how experienced investors simplify. The example sentences below are illustrative, not Yuanshi's wording.
| Audience | Lead with | Illustrative example sentence |
|---|---|---|
| Non-specialist investor | A known AI milestone | "Language models predict the next word; a cell model aims to predict a cell's next state." |
| Scientific audience | The mechanism | "A prediction is only real once bench data confirms it and updates the model." |
| Business media | The category shift | "The pitch is not a drug; it is infrastructure that learns from every experiment." |
The rare opportunity for Singapore, China and Asia startups
According to the Chapman University Survey of American Fears, Wave 12 (2026), public speaking ranked #51 of 79 fears, with 28.9 percent of Americans afraid or very afraid — a US survey, not an Asian one. Fear is only half the picture. For technical founders the everyday risks are quieter: confusion when the science gets dense, silence when a room stops engaging, ghosting after a promising meeting, rejection that is really a follow-up problem. Stronger speaking may help a team use a window like this one, but outcomes depend on many factors beyond speaking, and nothing here is a promise. Clearer speaking may also help people feel heard at work or at home, though that depends on many factors beyond speaking.
The transformation to aim for: from a pitch you rehearse to one your audience can follow. Jason Lim's Presentation Skills Coaching Program uses the P.I.T.C.H. method, by application. Apply, share your current pitch, and work through it step by step. Start here.
Illustration note: the image above is an original illustrative graphic created for this article — a designed graphic, not a photograph, and not sourced from Yuanshi, Legend Capital or any investor.
